Products
IP Intelligence Reports
Patexia Concierge
Patent Analyzer
Trademarks Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Login
Join
Book a Meeting
Back to All Articles
Browse articles with tag: Bpcia
You must be logged in to create a new article
All Articles
Pedram Sameni
Nov 3, 2022
•
ANDA Litigation
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Jun 26, 2017
•
Featured
Janssen and Celltrion: Remicade Biosimilar Patent Dance
Written by Daniel A. Kamkar and Agnes Juang, Ph.D. Janssen Biotech Inc. and Celltrion Healthcare have taken the next step...
Read More
0 Likes
0 Favorites
0 Comments
Mikele Bicolli
Apr 19, 2024
•
Patent Prosecution
USPTO Proposes Patent Fee Adjustments for FY 2025
The United States Patent and Trademark Office (USPTO) is proposing adjustments to patent fees for fiscal year 2025. These changes,...
Read More
1 Likes
0 Favorites
0 Comments
Featured